ArticleOncology reports2015

Aberrant hypomethylation-mediated CD147 overexpression promotes aggressive tumor progression in human prostate cancer.

Yu-Xiang Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.